Epidemiology of Metastatic Castration-Resistant Prostate Cancer (mCRPC): Current Data and Future Predictions

Metastatic castration-resistant prostate cancer (mCRPC) represents a significant challenge in the field of oncology, as it is a leading cause of cancer-related mortality among men worldwide. Despite advances in treatment and management, the epidemiology of mCRPC continues to evolve, influenced by factors such as demographics, geographical variations, and the emergence of new therapeutic options. This…

Prostate Cancer Market Insight: Comprehensive Analysis and Forecast

Prostate Cancer Market Insight: Comprehensive Analysis and Forecast “The total market size for metastatic castration-resistant prostate cancer (mCRPC) in the seven major markets (7MM) was projected to be approximately USD 7 billion in 2023, with expectations for continued positive growth by 2034.” Prostate cancer remains one of the most prevalent cancers among men globally, significantly…